Cargando…

In silico design and validation of a time-varying PID controller for an artificial pancreas with intraperitoneal insulin delivery and glucose sensing

Type 1 diabetes (T1D) is a chronic autoimmune disease featured by the loss of beta cell function and the need for lifetime insulin replacement. Over the recent decade, the use of automated insulin delivery systems (AID) has shifted the paradigm of treatment: the availability of continuous subcutaneo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalla Libera, Alberto, Toffanin, Chiara, Drecogna, Martina, Galderisi, Alfonso, Pillonetto, Gianluigi, Cobelli, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AIP Publishing LLC 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205143/ https://www.ncbi.nlm.nih.gov/pubmed/37229215 http://dx.doi.org/10.1063/5.0145446

Ejemplares similares

Modeling Intraperitoneal Insulin Absorption in Patients with Type 1 Diabetes
por: Schiavon, Michele, et al.
Publicado: (2021)

Design and Evaluation of a Robust PID Controller for a Fully Implantable Artificial Pancreas
por: Huyett, Lauren M., et al.
Publicado: (2015)

Closed-form expressions and nonparametric estimation of COVID-19 infection rate()
por: Bisiacco, Mauro, et al.
Publicado: (2022)

Artificial Pancreas: Past, Present, Future
por: Cobelli, Claudio, et al.
Publicado: (2011)

Closed-Loop Insulin Delivery Using a Subcutaneous Glucose Sensor and Intraperitoneal Insulin Delivery: Feasibility study testing a new model for the artificial pancreas
por: Renard, Eric, et al.
Publicado: (2010)

Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia
por: Breton, Marc, et al.
Publicado: (2012)

Systematically In Silico Comparison of Unihormonal and Bihormonal Artificial Pancreas Systems
por: Gao, Xiaoteng, et al.
Publicado: (2013)

The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes
por: Kovatchev, Boris, et al.
Publicado: (2016)

In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes
por: Schiavon, Michele, et al.
Publicado: (2020)

Study Design and Data Analysis of Artificial Pancreas Device Systems with Closed-Loop Glucose-Sensing Insulin Delivery
por: Shankara, Sravya B., et al.
Publicado: (2021)

The rs7903146 Variant in the TCF7L2 Gene Increases the Risk of Prediabetes/Type 2 Diabetes in Obese Adolescents by Impairing β-Cell Function and Hepatic Insulin Sensitivity
por: Cropano, Catrina, et al.
Publicado: (2017)

Characterization of Cyclic Olefin Copolymers for Insulin Reservoir in an Artificial Pancreas
por: Mallegni, Norma, et al.
Publicado: (2023)

Tracking the time course of reproduction number and lockdown’s effect on human behaviour during SARS-CoV-2 epidemic: nonparametric estimation
por: Pillonetto, G., et al.
Publicado: (2021)

PID_TUNE: A PID Autotuning Software Tool on UNICOS CPC
por: Blanco Vinuela, Enrique, et al.
Publicado: (2015)

Closed-Loop Artificial Pancreas Systems: Physiological Input to Enhance Next-Generation Devices
por: Kudva, Yogish C., et al.
Publicado: (2014)

Response to Comment on Pinsker et al. Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas. Diabetes Care 2016;39:1135–1142
por: Pinsker, Jordan E., et al.
Publicado: (2017)

COVID-19 epidemic control using short-term lockdowns for collective gain
por: Bisiacco, Mauro, et al.
Publicado: (2021)

The Artificial Pancreas
por: Radziuk, Jerry
Publicado: (2012)

LHCb reconstruction and PID
por: Santana Rangel, Murilo
Publicado: (2020)

Advanced PID control
por: Astrom, Karl J, et al.
Publicado: (2006)

Advances in PID control
por: Tan Kok Kiong, et al.
Publicado: (1999)

Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas
por: Kovatchev, Boris P., et al.
Publicado: (2014)

In-silico evaluation of an artificial pancreas achieving automatic glycemic control in patients with type 1 diabetes
por: Liu, Wenping, et al.
Publicado: (2023)

Pelvic Inflammatory Disease (PID)
por: Soper, David E.
Publicado: (1996)

PID: the Pathway Interaction Database
por: Schaefer, Carl F., et al.
Publicado: (2009)

Process identification and PID control
por: Sung, Su Whan, et al.
Publicado: (2009)

Telemedical Artificial Pancreas: PARIS (Páncreas Artificial Telemédico Inteligente) research project
por: de Leiva, Alberto, et al.
Publicado: (2009)

Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator
por: Visentin, Roberto, et al.
Publicado: (2016)

Artificial bee colony algorithm based PID controller for steel stripe deviation control system
por: Wang, He, et al.
Publicado: (2022)

Insulin and the Diabetic Pancreas
por: Susman, William
Publicado: (1928)

Pilot Studies of Wearable Outpatient Artificial Pancreas in Type 1 Diabetes
por: Cobelli, Claudio, et al.
Publicado: (2012)

Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas
por: Kesavadev, Jothydev, et al.
Publicado: (2020)

The PID Life Index: an interactive tool to measure the status of the PID healthcare environment in any given country
por: Solís, Leire, et al.
Publicado: (2022)

Pattern recognition and PID for COMPASS RICH-1
por: Abbon, P., et al.
Publicado: (2009)

The Artificial Pancreas: Are We There Yet?
por: Cefalu, William T., et al.
Publicado: (2014)

Report from the ALICE PID panel
por: Klanner, Robert, et al.
Publicado: (1998)

PID performance in Run 2 at LHCb
por: Seuthe, Alex
Publicado: (2021)

Faddeev calculations of $\piD$ scattering
por: Thomas, A W
Publicado: (1976)

PID performance in Run 2 at LHCb
por: Seuthe, Alex
Publicado: (2020)

PID performance in Run2 at LHCb
por: Seuthe, Alex
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ujdosm1ak0rlbk3fl0puiksd9e